<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 21 - FOOD AND DRUGS</title></head><body>
<span style="font-weight:bold;font-size:12pt;">21 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 1999 Edition</span><br/>
<span style="font-size:10pt">Title 21 - FOOD AND DRUGS</span><br/>
<span style="font-size:10pt">CHAPTER 9 - FEDERAL FOOD, DRUG, AND COSMETIC ACT</span><br/>
<span style="font-size:10pt">SUBCHAPTER V - DRUGS AND DEVICES</span><br/>
<span style="font-size:10pt">Part A - Drugs and Devices</span><br/>
<span style="font-size:10pt">Sec. 356c - Discontinuance of life saving product</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:21_356c  usckey:210000000035600000000000c00000000 currentthrough:20000123 documentPDFPage:155 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER V/Part A/Sec. 356c -->
<!-- itemsortkey:210AAHY -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER V-DRUGS AND DEVICES!@!Part A-Drugs and Devices!@!Sec. 356c -->
<!-- field-start:head -->
<h3 class="section-head">&sect;356c. Discontinuance of life saving product</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">A manufacturer that is the sole manufacturer of a drug&mdash;</p>
<p class="statutory-body-1em">(1) that is&mdash;</p>
<p class="statutory-body-2em">(A) life-supporting;</p>
<p class="statutory-body-2em">(B) life-sustaining; or</p>
<p class="statutory-body-2em">(C) intended for use in the prevention of a debilitating disease or condition;</p>
<br class="Q04" />
<p class="statutory-body-1em">(2) for which an application has been approved under section 355(b) or 355(j) of this title; and</p>
<p class="statutory-body-1em">(3) that is not a product that was originally derived from human tissue and was replaced by a recombinant product,</p>
<br class="Q04" />
<p class="statutory-body-block">shall notify the Secretary of a discontinuance of the manufacture of the drug at least 6 months prior to the date of the discontinuance.</p>
<h4 class="subsection-head">(b) Reduction in notification period</h4>
<p class="statutory-body">The notification period required under subsection (a) of this section for a manufacturer may be reduced if the manufacturer certifies to the Secretary that good cause exists for the reduction, such as a situation in which&mdash;</p>
<p class="statutory-body-1em">(1) a public health problem may result from continuation of the manufacturing for the 6-month period;</p>
<p class="statutory-body-1em">(2) a biomaterials shortage prevents the continuation of the manufacturing for the 6-month period;</p>
<p class="statutory-body-1em">(3) a liability problem may exist for the manufacturer if the manufacturing is continued for the 6-month period;</p>
<p class="statutory-body-1em">(4) continuation of the manufacturing for the 6-month period may cause substantial economic hardship for the manufacturer;</p>
<p class="statutory-body-1em">(5) the manufacturer has filed for bankruptcy under chapter 7 or 11 of title 11; or</p>
<p class="statutory-body-1em">(6) the manufacturer can continue the distribution of the drug involved for 6 months.</p>
<h4 class="subsection-head">(c) Distribution</h4>
<p class="statutory-body">To the maximum extent practicable, the Secretary shall distribute information on the discontinuation of the drugs described in subsection (a) of this section to appropriate physician and patient organizations.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;506C, as added Pub. L. 105&ndash;115, title I, &sect;131(a), Nov. 21, 1997, 111 Stat. 2332.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:effectivedate-note -->
<h4 class="note-head">Effective Date</h4>
<p class="note-body">Section effective 90 days after Nov. 21, 1997, except as otherwise provided, see section 501 of Pub. L. 105&ndash;115, set out as an Effective Date of 1997 Amendment note under section 321 of this title.</p>
<!-- field-end:effectivedate-note -->
<!-- field-end:notes -->


</body></html>